financetom
Business
financetom
/
Business
/
Innergex Maintained at Outperform at BMO Following Sale of a Minority Interest in Texas Assets; Price Target Raised to C$11.00
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Innergex Maintained at Outperform at BMO Following Sale of a Minority Interest in Texas Assets; Price Target Raised to C$11.00
Jun 21, 2024 9:14 AM

11:52 AM EDT, 06/21/2024 (MT Newswires) -- BMO Capital Markets on Friday reiterated its outperform rating on the shares of Innergex Renewable Energy ( INGXF ) after the company sold a minority stake in its Texas renewable-power assets for US$188 million.

"INE's minority sale of its Texas renewable fleet for US$188M strengthens its balance sheet and unlocks value but the implied 9x EV/EBITDA sale valuation was underwhelming in our opinion. While we view the transaction as neutral (no expected change in FCF/sh), our target price goes to $11 vs. $9, reflecting the recent decline in 10-year Government of Canada bond yields and improved renewables sentiment of late (target valuation to 10.5x EBITDA vs. 10x). Maintain Outperform rating," analyst Ben Pham wrote.

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Price: 10.18, Change: -0.06, Percent Change: -0.59

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kalvista Pharmaceuticals Insider Sold Shares Worth $258,337, According to a Recent SEC Filing
Kalvista Pharmaceuticals Insider Sold Shares Worth $258,337, According to a Recent SEC Filing
May 21, 2024
06:01 PM EDT, 05/21/2024 (MT Newswires) -- Benjamin L Palleiko, Director, CEO, on May 17, 2024, sold 21,959 shares in Kalvista Pharmaceuticals ( KALV ) for $258,337. Following the Form 4 filing with the SEC, Palleiko has control over a total of 216,387 shares of the company, with 216,387 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1348911/000141588924014001/xslF345X03/form4-05212024_090551.xml ...
Injured passengers on Singapore Airlines face varied compensation
Injured passengers on Singapore Airlines face varied compensation
May 21, 2024
May 21 (Reuters) - Passengers injured by severe turbulence on a Singapore Airlines flight on Tuesday are likely eligible for compensation, but the amount each receives could differ dramatically even for identical injuries due to an international treaty. One passenger died and the airline said 30 passengers were treated for injuries after a flight from London to Singapore made an...
Uruguay antitrust regulator blocks Mexican breadmaker Bimbo's purchase of Pagnifique
Uruguay antitrust regulator blocks Mexican breadmaker Bimbo's purchase of Pagnifique
May 21, 2024
MONTEVIDEO, May 21 (Reuters) - Uruguay's antitrust regulator blocked Mexican breadmaking giant Bimbo's planned purchase of local breadmaker Pagnifique on Tuesday, citing risks to market concentration if Bimbo were able to carry out the deal. Bimbo can now appeal the decision. ...
Shaken passengers arrive in Singapore after turbulence-hit flight
Shaken passengers arrive in Singapore after turbulence-hit flight
May 21, 2024
By Kokkai Ng and Joseph Campbell SINGAPORE, May 22 (Reuters) - Many passengers on a Singapore Airlines flight hit by heavy turbulence which left dozens injured and one dead from a suspected heart attack finally reached Singapore on Wednesday morning. Dozens of passengers quietly filed off a Singapore Airlines jet, mostly ignoring media awaiting their arrival. Some responded to shouted...
Copyright 2023-2026 - www.financetom.com All Rights Reserved